Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality
Article
[키워드] activity
acute respiratory distress
Admission
Analysis
analyzed
anti-inflammatory property
ARDS
Belgium
Biomarker
blood cell
blood sample
C-reactive protein
chemerin
chemotactic
ChemR23
Clinical practice
CMKLR1
collected
Concentration
correlated
COVID-19
COVID-19 patient
COVID-19 patients
death
Deceased
demonstrated
disease
evaluate
evaluated
expression
Extracellular
flow cytometry
healthy control
ICU
ICU patient
identify
IHC
immunohistochemistry
Increased
independent risk factor
Inflammatory biomarker
inflammatory conditions
intensive care
Lung pathology
lung tissue
marker
mechanism
Mortality
Necrosis
Patient
plasma
predict
prediction
Prognostic value
Protein
severity
significantly higher
smooth muscle cell
subtype
survival
survivor
syndrome
Viral pneumonia
[DOI] 10.3389/fimmu.2022.941663 PMC 바로가기
[DOI] 10.3389/fimmu.2022.941663 PMC 바로가기